Evaluation of Centration of Intraocular Lens With Two Settings for Capsulorhexis With Femtosecond Laser
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02315456|
Recruitment Status : Completed
First Posted : December 11, 2014
Last Update Posted : February 10, 2020
|Condition or disease||Intervention/treatment||Phase|
|Capsulorhexis||Procedure: capsulorhexis||Not Applicable|
50 consecutive eyes undergoing cataract surgery will be studied. 25 eyes will have scanned capsule centration and 25 will have pupil centration. Retroillumination slitlamp photographs will be taken 10-30 days after surgery with dilated pupils. The amount of capsule overlapping the IOL will be documented. The horizontal, vertical and symmetricity of overlap will be calculated.
Each group will have 20 eyes with an additional 5 eyes in each group to account for drop outs or poor quality images.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||50 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Prospective Randomized Evaluation of Centration of Intraocular Lens With Two Laser Settings for Capsulorhexis With Femtosecond Laser|
|Actual Study Start Date :||December 2014|
|Actual Primary Completion Date :||August 9, 2016|
|Actual Study Completion Date :||August 9, 2016|
Capsulorhexis made with capsule centration
Capsulorhexis made with pupil centration
- Overlap of the Continuous Curvilinear Capsulorhexis margin over the IOL [ Time Frame: 10-30 days post surgery ]
The horizontal and vertical overlap will be calculated. Horizontal overlap= Overlap of the temporal half versus the nasal half Vertical overlap= overlap of the superior half versus the inferior half of the IOL.
Symmetricity of overlap= Horizontal overlap/vertical overlap
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02315456
|United States, Illinois|
|Chicago, Illinois, United States, 60611|
|Principal Investigator:||Surendra Basti, MD||Northwestern University|